Dr Anne Briançon is assistant professor in the HP2 Laboratory (INSERMU1300), University Grenoble Alpes. She is mainly focusing on vascular and cerebral consequences of intermittent hypoxia, one of the main pathophysiological traits of Obstructive Sleep Apnea Syndrome. She is using cellular and animal models of intermittent hypoxia to decipher the physiopathological consequences of intermittent hypoxia, in the objective of proposing new therapeutical targets to treat the cardiovascular complications of obstructive sleep apnea.